Novadaq Technologies Inc.

Novadaq Technologies Inc.

February 12, 2008 07:00 ET

NOVADAQ's SPY System to be Featured During Live Broadcast of Robotic Surgery

SPY used to assess the quality of grafts during minimally invasive heart bypass

TORONTO, ONTARIO--(Marketwire - Feb. 12, 2008) -

Attention Business Editors:

Novadaq® Technologies Inc. (TSX:NDQ), a developer of real-time medical
imaging systems and image guided therapies for the operating room, today
announced that the SPY® Intra-operative Imaging System will be used during
a live on-line broadcast to confirm placement and assess the quality of
coronary artery bypass grafts performed by Christine McCarty, MD, using the
daVinci® S Surgical Robotic System. The broadcast will air today at 6 p.m.
EST and can be viewed on line at

During the broadcast, Dr. McCarty, chair of cardiac surgery at
PinnacleHealth, will complete double vessel bypass surgery on a beating heart.
Once the bypass grafts are completed and while the patient is still in the
operating room, Dr. McCarty will use the SPY System to visualize blood flow
through the grafts and in native tissue. Adequate blood flow in the graft and
native tissue may prevent the need for repeat surgery and reduce the potential
for post-operative complications. Dr. McCarty has been using the SPY System
routinely in her practice of cardiac surgery since November 2005. Dr. McCarty
will be available to answer questions electronically from the online audience
during the event.

Robotically-assisted minimally invasive cardiac surgical procedures
through small incisions can reduce the potential for some of the drawbacks of
traditional heart surgery, such as pain and scarring that typically results
from opening the chest. However, small incisions may also affect the cardiac
surgeon's ability to see all that they would normally see in an open chest
bypass procedure. During robotic procedures, SPY may enable surgeons to
visualize the blood flow in bypass grafts and blood vessels and therefore
assist in determining whether or not the grafts are functioning properly.

"PinnacleHealth is proud to showcase the joint use of leading edge
technologies - Novadaq's SPY Intra-operative System and Intuitive Surgical's
da Vinci® S Surgical System - demonstrating to the community that the latest
advances in medical care are available in central Pennsylvania," says Jean
Wiest, Vice President for Cardiopulmonary and Transport services at

About PinnacleHealth

PinnacleHealth includes four campuses (Community, Cumberland, Harrisburg
and Polyclinic), FamilyCare physician practices, home health and hospice
services, FirstPlace urgent care center and an array of healthcare services.
PinnacleHealth Heart & Vascular Institute has been the pioneer in
cardiovascular care in Central Pennsylvania since 1956 when our surgeons
performed the area's first open-heart surgery. We stay on the leading edge
today by applying emerging treatments and technology and through clinical
trials and research.

For more information about PinnacleHealth please visit:

About Novadaq Technologies

Novadaq Technologies Inc. (TSX:NDQ) develops and commercializes medical
imaging systems and real-time image guided therapies for use in the operating
room. Novadaq's proprietary ICG imaging systems can be used to visualize blood
vessels, nerves and the lymphatic system during a variety of surgical
procedures. Novadaq's SPY Imaging System, commercially available worldwide,
enables cardiac surgeons to visually assess coronary vasculature and bypass
graft functionality during the course of heart bypass surgery. The SPY System
is expandable to include upgrade kits for use during other surgeries such as
other cardiovascular, plastic, reconstructive and organ transplant surgery
allowing surgeons to evaluate blood flow and tissue and organ perfusion. In
addition, SPY is ideal for use during urological procedures enabling surgeons
to visualize vessels, tumors, the lymphatic system and potentially nerve
bundles. Novadaq's OPTTX® System is aimed at the diagnosis, evaluation and
treatment of wet Age-related Macular Degeneration (AMD) by using the same core
imaging technology that is used in the SPY Imaging System. Novadaq also offers
the FDA approved PINPOINT endoscopic system for visualizing native tissue
fluorescence which allows surgeons to differentiate between healthy and
cancerous tissue in the lung during thoracic surgery. Novadaq is also the
exclusive United States distributor of PLC Medical's CO2 HEART LASER™
System for TMR (Trans-Myocardial Revascularization). For more information,
please visit the company's website at

Forward-looking Statements

Certain statements included in this press release may be considered
forward-looking. Such statements involve known and unknown risks,
uncertainties and other factors that may cause actual results, performance or
achievements to be materially different from those implied by such statements,
and therefore these statements should not be read as guarantees of future
performance or results. All forward-looking statements are based on Novadaq's
current beliefs as well as assumptions made by and information currently
available to Novadaq and relate to, among other things, anticipated financial
performance, business prospects, strategies, regulatory developments, market
acceptance and future commitments. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the date
of this press release. Due to risks and uncertainties, including the risks and
uncertainties identified by Novadaq in its public securities filings; actual
events may differ materially from current expectations. Novadaq disclaims any
intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.

For further information: visit our website at

Contact Information